Walgreens Boots Alliance is a global healthcare leader that operates a chain of pharmacies, drugstores, and health and wellness retail outlets. The company is known for providing accessible pharmaceutical services and a wide range of health and beauty products. With a commitment to enhancing the health and well-being of its customers, Walgreens Boots Alliance focuses on delivering innovative healthcare solutions, including pharmacy services, immunizations, and health consultations. Additionally, the company engages in retail pharmacy and wholesale distribution, partnering with various healthcare providers to improve patient outcomes and ensure the availability of essential medications and healthcare products.
Merger and acquisitions activity in US peaked in 2021, expected to reverse in 2025 with more larger-scale deals due to lower interest rates and M/A-friendly FTC. Check out 5 potential targets.
(BPT) - Nobody wants to feel sick during the holiday season. From the hustle and bustle of office parties, school programs, holiday concerts, parades and gatherings with loved ones, the festivities are endless. But just as our calendars fill up, cold and flu season hits, creating a perfect storm of germs when we most want to stay healthy.
Shares of pharmacy chain Walgreens Boots Alliance (NASDAQ:WBA) jumped 19.9% in the afternoon session after The Wall Street Journal reported that the company (WBA) is in talks to sell itself to private equity firm Sycamore Partners. Most acquisitions close at a premium, raising the possibility that existing investors could exit their positions at a higher price if Walgreens strikes a deal with a buyer.
Walgreens retreated 3.26% to $10.08 in Wednesday's pre-market trading, following Tuesday's 20% surge, as prominent market voices weighed in on the potential private takeover by Sycamore Partners.
Walgreens Boots Alliance Inc (NASDAQ:WBA) shares are trading higher Tuesday afternoon following a report suggesting the company is in talks to be acquired by a private-equity firm.
The U.S. stock market lacked direction on Tuesday morning as investors stayed on the sidelines ahead of Wednesday’s release of November inflation data, a critical report that could influence the Federal Reserve’s decision on a potential interest rate cut next week.
Over the past 12 months, a group of 10 large-cap stocks have underperformed all others. Here’s an updated look at the top 10 worst performing large-caps, along with their one-year price returns.
This is one of the most difficult questions in investing because it’s filled with emotions. Long-term investors tend to stay in losing stocks to try and “make it back” to their breakeven level.
